PCOS: metabolic impact and long-term management.
Explore this paper's citation graph
Summary
There is a discrepancy between increased cardiovascular risk at young age and postmenopausal number of cardiovascular events, probablu depending on changes in androgen ovarian function after the forties, however, changes with age of metabolic profile in women with PCOS have not been studied yet and many more data are necessary.
- Type
- article
- Published
- 2012-12-01
- Cited by
- 27
- References
- 0
- OpenAlex
- https://openalex.org/W106849
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23687550
Keywords
Medicine, Polycystic ovary, Androgen Excess, Endometrial cancer, Gynecology
References
No references recorded for this paper.
Cited by
- Platelet‐derived growth factor BB and DD and angiopoietin1 are altered in follicular fluid from polycystic ovary syndrome patients
- Polycystic ovary syndrome
- [Role of genetic and environmental factors in the development of polycystic ovary syndrome].
- [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
- Comparative evaluation of sonographic ovarian morphology of Indian women with polycystic ovary syndrome versus those of normal women
- Infertility and the presence of insulin resistance are associated with increased oxidative stress in young, non-obese Turkish women with polycystic ovary syndrome.
- Female infertility of endocrine origin.
- Metformin and Other Insulin Sensitizers in Polycystic Ovary Syndrome
- Maternal Undernutrition Induces Premature Reproductive Senescence in Adult Female Rat Offspring
- Effect of metformin on sleep disorders in adolescent girls with polycystic ovarian syndrome.
- Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis
- Female infertility of endocrine origin Infertilidade feminina de origem endócrina
- Cystatin C, a novel cardiometabolic risk marker in women with polycystic ovary syndrome
- Effects of different doses of metformin treatment for 6 months on aberrant crypt foci in Chinese patients with impaired glucose tolerance
- Menopausal Implications of Polycystic Ovarian Syndrome
- Serum LBP Is Associated with Insulin Resistance in Women with PCOS
- Fetuin-A levels in lean and obese women with polycystic ovary syndrome.
- Polycystic Ovarian Syndrome: Insights into Pathogenesis, Diagnosis, Prognosis, Pharmacological and Non-Pharmacological Treatment
- Pregnancy-related outcomes for women with polycystic ovary syndrome
- N1-methylnicotinamide as a possible modulator of cardiovascular risk markers in polycystic ovary syndrome.
Related papers
- No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide.
- The Role of Androgen Excess in Metabolic Dysfunction in Women : Androgen Excess and Female Metabolic Dysfunction.
- Early Origins of polycystic ovary syndrome: hypotheses may change without notice.
- EFFECTS OF LH SUPPRESSION IN POLYCYSTIC OVARY SYNDROME
- Role of Androgen Excess on Metabolic Aberrations and Cardiovascular Risk in Women with Polycystic Ovary Syndrome
- Ovarian 11β-hydroxysteroid dehydrogenase (11βHSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): apparent role for ovarian androgens.
- Role of androgen ratios in the prediction of the metabolic phenotype in polycystic ovary syndrome
- Prenatal androgen excess programs metabolic derangements in pubertal female rats.
- Metformin for the prevention of androgen deprivation induced metabolic syndrome, obesity and type 2 diabetes.